Clinical Trial Update: Positron Emission Tomography to Assess the Effect of Camzyos on Ischaemia in HOCM: PEACH Trial [NA]

View source ↗

Summary

A clinical trial update describing the PEACH study, which will use PET imaging to evaluate whether mavacamten (Camzyos) reduces myocardial ischemia in patients …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Obstructive Cardiomyopathy
• Left Ventricular Outflow Tract Obstruction
• Myocardial Ischemia

Drugs mentioned

• CAMZYOS (MAVACAMTEN)

Snippet

Sponsor: University of Manchester | Conditions: Hypertrophic Obstructive Cardiomyopathy \(HOCM\), Left Ventricular Outflow Tract Obstruction | NA | Status: NOT_YET_RECRUITING